Global Transdermal Patch Sales 麻豆原创 Report 2023

Publication ID:

PB501231936

Publication Date:

January 2, 2023

Pages:

136

Publisher:

MRRPB5

Countries:

Global [1]

USD 4,000.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.
麻豆原创 Analysis and Insights: Global Transdermal Patch 麻豆原创
Due to the COVID-19 pandemic, the global Transdermal Patch market size is estimated to be worth US$ 6793 million in 2022 and is forecast to a readjusted size of US$ 8726.9 million by 2029 with a CAGR of 3.6% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, Methyl Salicylate-based Patch accounting for % of the Transdermal Patch global market in 2022, is projected to value US$ million by 2029, growing at a revised % CAGR from 2023 to 2029. While Rx Channel segment is altered to an % CAGR throughout this forecast period.
Transdermal Patches are mainly classified into the following types: Methyl Salicylate-based Patches, Rivastigmine Patches, Fentanyl Patches, Lidocaine Patches, Diclofenac Patches, Nicotine Patches and others. Methyl Salicylate-based segment accounted for the larger part of the revenue market, with 18%, followed by Lidocaine Patches, with 15%.
Transdermal Patches can delivery drugs through Rx Channel or OTC Channel. The former took a larger market share, with its sales volume accounting for about 76% of the total.
Hisamitsu Pharmaceutical, Johnson & Johnson, Nitto Denko and Mylan are the Top 4 players of the global Transdermal Patch market. They took up about 42% of the global market in 2019.
Global Transdermal Patch Scope and 麻豆原创 Size
The global Transdermal Patch market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Transdermal Patch market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2029.
Segment by Type
Methyl Salicylate-based Patch
Rivastigmine Transdermal Patch
Fentanyl Transdermal Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Transdermal Patch
Others
Segment by Application
Rx Channel
OTC Channel
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Hisamitsu Pharmaceutical
Johnson & Johnson
Novartis
UCB Pharma
Mylan
Teva Pharmaceutical
Nitto Denko
骋谤眉苍别苍迟丑补濒
IBSA Group
GSK
Luye Pharma Group
Pfizer
Chattem
Dr Reddy鈥檚 Laboratories
Bayer
Mundipharma
Endo International
Beijing Tide Pharmaceutical

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Transdermal Patch 麻豆原创 Overview
1.1 Transdermal Patch Product Scope
1.2 Transdermal Patch Segment by Type
1.2.1 Global Transdermal Patch Sales by Type (2018 & 2022 & 2029)
1.2.2 Methyl Salicylate-based Patch
1.2.3 Rivastigmine Transdermal Patch
1.2.4 Fentanyl Transdermal Patch
1.2.5 Lidocaine Patch
1.2.6 Diclofenac Patch
1.2.7 Nicotine Transdermal Patch
1.2.8 Others
1.3 Transdermal Patch Segment by Application
1.3.1 Global Transdermal Patch Sales Comparison by Application (2018 & 2022 & 2029)
1.3.2 Rx Channel
1.3.3 OTC Channel
1.4 Transdermal Patch 麻豆原创 Estimates and Forecasts (2018-2029)
1.4.1 Global Transdermal Patch 麻豆原创 Size in Value Growth Rate (2018-2029)
1.4.2 Global Transdermal Patch 麻豆原创 Size in Volume Growth Rate (2018-2029)
1.4.3 Global Transdermal Patch Price Trends (2018-2029)
2 Transdermal Patch Estimates and Forecasts by Region
2.1 Global Transdermal Patch 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2 Global Transdermal Patch Retrospective 麻豆原创 Scenario by Region (2018-2023)
2.2.1 Global Transdermal Patch Sales 麻豆原创 Share by Region (2018-2023)
2.2.2 Global Transdermal Patch Revenue 麻豆原创 Share by Region (2018-2023)
2.3 Global Transdermal Patch 麻豆原创 Estimates and Forecasts by Region (2024-2029)
2.3.1 Global Transdermal Patch Sales Estimates and Forecasts by Region (2024-2029)
2.3.2 Global Transdermal Patch Revenue Forecast by Region (2024-2029)
2.4 Geographic 麻豆原创 Analysis: 麻豆原创 Facts & Figures
2.4.1 United States Transdermal Patch Estimates and Projections (2018-2029)
2.4.2 Europe Transdermal Patch Estimates and Projections (2018-2029)
2.4.3 China Transdermal Patch Estimates and Projections (2018-2029)
2.4.4 Japan Transdermal Patch Estimates and Projections (2018-2029)
2.4.5 Southeast Asia Transdermal Patch Estimates and Projections (2018-2029)
2.4.6 India Transdermal Patch Estimates and Projections (2018-2029)
3 Global Transdermal Patch Competition Landscape by Players
3.1 Global Top Transdermal Patch Players by Sales (2018-2023)
3.2 Global Top Transdermal Patch Players by Revenue (2018-2023)
3.3 Global Transdermal Patch 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Transdermal Patch as of 2022)
3.4 Global Transdermal Patch Average Price by Company (2018-2023)
3.5 Manufacturers Transdermal Patch Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Transdermal Patch 麻豆原创 Size by Type
4.1 Global Transdermal Patch Historic 麻豆原创 Review by Type (2018-2023)
4.1.1 Global Transdermal Patch Sales by Type (2018-2023)
4.1.2 Global Transdermal Patch Revenue by Type (2018-2023)
4.1.3 Global Transdermal Patch Price by Type (2018-2023)
4.2 Global Transdermal Patch 麻豆原创 Estimates and Forecasts by Type (2024-2029)
4.2.1 Global Transdermal Patch Sales Forecast by Type (2024-2029)
4.2.2 Global Transdermal Patch Revenue Forecast by Type (2024-2029)
4.2.3 Global Transdermal Patch Price Forecast by Type (2024-2029)
5 Global Transdermal Patch 麻豆原创 Size by Application
5.1 Global Transdermal Patch Historic 麻豆原创 Review by Application (2018-2023)
5.1.1 Global Transdermal Patch Sales by Application (2018-2023)
5.1.2 Global Transdermal Patch Revenue by Application (2018-2023)
5.1.3 Global Transdermal Patch Price by Application (2018-2023)
5.2 Global Transdermal Patch 麻豆原创 Estimates and Forecasts by Application (2024-2029)
5.2.1 Global Transdermal Patch Sales Forecast by Application (2024-2029)
5.2.2 Global Transdermal Patch Revenue Forecast by Application (2024-2029)
5.2.3 Global Transdermal Patch Price Forecast by Application (2024-2029)
6 United States Transdermal Patch 麻豆原创 Facts & Figures
6.1 United States Transdermal Patch Sales by Company
6.1.1 United States Transdermal Patch Sales by Company (2018-2023)
6.1.2 United States Transdermal Patch Revenue by Company (2018-2023)
6.2 United States Transdermal Patch Sales Breakdown by Type
6.2.1 United States Transdermal Patch Sales Breakdown by Type (2018-2023)
6.2.2 United States Transdermal Patch Sales Breakdown by Type (2024-2029)
6.3 United States Transdermal Patch Sales Breakdown by Application
6.3.1 United States Transdermal Patch Sales Breakdown by Application (2018-2023)
6.3.2 United States Transdermal Patch Sales Breakdown by Application (2024-2029)
7 Europe Transdermal Patch 麻豆原创 Facts & Figures
7.1 Europe Transdermal Patch Sales by Company
7.1.1 Europe Transdermal Patch Sales by Company (2018-2023)
7.1.2 Europe Transdermal Patch Revenue by Company (2018-2023)
7.2 Europe Transdermal Patch Sales Breakdown by Type
7.2.1 Europe Transdermal Patch Sales Breakdown by Type (2018-2023)
7.2.2 Europe Transdermal Patch Sales Breakdown by Type (2024-2029)
7.3 Europe Transdermal Patch Sales Breakdown by Application
7.3.1 Europe Transdermal Patch Sales Breakdown by Application (2018-2023)
7.3.2 Europe Transdermal Patch Sales Breakdown by Application (2024-2029)
8 China Transdermal Patch 麻豆原创 Facts & Figures
8.1 China Transdermal Patch Sales by Company
8.1.1 China Transdermal Patch Sales by Company (2018-2023)
8.1.2 China Transdermal Patch Revenue by Company (2018-2023)
8.2 China Transdermal Patch Sales Breakdown by Type
8.2.1 China Transdermal Patch Sales Breakdown by Type (2018-2023)
8.2.2 China Transdermal Patch Sales Breakdown by Type (2024-2029)
8.3 China Transdermal Patch Sales Breakdown by Application
8.3.1 China Transdermal Patch Sales Breakdown by Application (2018-2023)
8.3.2 China Transdermal Patch Sales Breakdown by Application (2024-2029)
9 Japan Transdermal Patch 麻豆原创 Facts & Figures
9.1 Japan Transdermal Patch Sales by Company
9.1.1 Japan Transdermal Patch Sales by Company (2018-2023)
9.1.2 Japan Transdermal Patch Revenue by Company (2018-2023)
9.2 Japan Transdermal Patch Sales Breakdown by Type
9.2.1 Japan Transdermal Patch Sales Breakdown by Type (2018-2023)
9.2.2 Japan Transdermal Patch Sales Breakdown by Type (2024-2029)
9.3 Japan Transdermal Patch Sales Breakdown by Application
9.3.1 Japan Transdermal Patch Sales Breakdown by Application (2018-2023)
9.3.2 Japan Transdermal Patch Sales Breakdown by Application (2024-2029)
10 Southeast Asia Transdermal Patch 麻豆原创 Facts & Figures
10.1 Southeast Asia Transdermal Patch Sales by Company
10.1.1 Southeast Asia Transdermal Patch Sales by Company (2018-2023)
10.1.2 Southeast Asia Transdermal Patch Revenue by Company (2018-2023)
10.2 Southeast Asia Transdermal Patch Sales Breakdown by Type
10.2.1 Southeast Asia Transdermal Patch Sales Breakdown by Type (2018-2023)
10.2.2 Southeast Asia Transdermal Patch Sales Breakdown by Type (2024-2029)
10.3 Southeast Asia Transdermal Patch Sales Breakdown by Application
10.3.1 Southeast Asia Transdermal Patch Sales Breakdown by Application (2018-2023)
10.3.2 Southeast Asia Transdermal Patch Sales Breakdown by Application (2024-2029)
11 India Transdermal Patch 麻豆原创 Facts & Figures
11.1 India Transdermal Patch Sales by Company
11.1.1 India Transdermal Patch Sales by Company (2018-2023)
11.1.2 India Transdermal Patch Revenue by Company (2018-2023)
11.2 India Transdermal Patch Sales Breakdown by Type
11.2.1 India Transdermal Patch Sales Breakdown by Type (2018-2023)
11.2.2 India Transdermal Patch Sales Breakdown by Type (2024-2029)
11.3 India Transdermal Patch Sales Breakdown by Application
11.3.1 India Transdermal Patch Sales Breakdown by Application (2018-2023)
11.3.2 India Transdermal Patch Sales Breakdown by Application (2024-2029)
12 Company Profiles and Key Figures in Transdermal Patch Business
12.1 Hisamitsu Pharmaceutical
12.1.1 Hisamitsu Pharmaceutical Corporation Information
12.1.2 Hisamitsu Pharmaceutical Business Overview
12.1.3 Hisamitsu Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
12.1.4 Hisamitsu Pharmaceutical Transdermal Patch Products Offered
12.1.5 Hisamitsu Pharmaceutical Recent Development
12.2 Johnson & Johnson
12.2.1 Johnson & Johnson Corporation Information
12.2.2 Johnson & Johnson Business Overview
12.2.3 Johnson & Johnson Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
12.2.4 Johnson & Johnson Transdermal Patch Products Offered
12.2.5 Johnson & Johnson Recent Development
12.3 Novartis
12.3.1 Novartis Corporation Information
12.3.2 Novartis Business Overview
12.3.3 Novartis Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
12.3.4 Novartis Transdermal Patch Products Offered
12.3.5 Novartis Recent Development
12.4 UCB Pharma
12.4.1 UCB Pharma Corporation Information
12.4.2 UCB Pharma Business Overview
12.4.3 UCB Pharma Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
12.4.4 UCB Pharma Transdermal Patch Products Offered
12.4.5 UCB Pharma Recent Development
12.5 Mylan
12.5.1 Mylan Corporation Information
12.5.2 Mylan Business Overview
12.5.3 Mylan Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
12.5.4 Mylan Transdermal Patch Products Offered
12.5.5 Mylan Recent Development
12.6 Teva Pharmaceutical
12.6.1 Teva Pharmaceutical Corporation Information
12.6.2 Teva Pharmaceutical Business Overview
12.6.3 Teva Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
12.6.4 Teva Pharmaceutical Transdermal Patch Products Offered
12.6.5 Teva Pharmaceutical Recent Development
12.7 Nitto Denko
12.7.1 Nitto Denko Corporation Information
12.7.2 Nitto Denko Business Overview
12.7.3 Nitto Denko Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
12.7.4 Nitto Denko Transdermal Patch Products Offered
12.7.5 Nitto Denko Recent Development
12.8 骋谤眉苍别苍迟丑补濒
12.8.1 骋谤眉苍别苍迟丑补濒 Corporation Information
12.8.2 骋谤眉苍别苍迟丑补濒 Business Overview
12.8.3 骋谤眉苍别苍迟丑补濒 Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
12.8.4 骋谤眉苍别苍迟丑补濒 Transdermal Patch Products Offered
12.8.5 骋谤眉苍别苍迟丑补濒 Recent Development
12.9 IBSA Group
12.9.1 IBSA Group Corporation Information
12.9.2 IBSA Group Business Overview
12.9.3 IBSA Group Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
12.9.4 IBSA Group Transdermal Patch Products Offered
12.9.5 IBSA Group Recent Development
12.10 GSK
12.10.1 GSK Corporation Information
12.10.2 GSK Business Overview
12.10.3 GSK Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
12.10.4 GSK Transdermal Patch Products Offered
12.10.5 GSK Recent Development
12.11 Luye Pharma Group
12.11.1 Luye Pharma Group Corporation Information
12.11.2 Luye Pharma Group Business Overview
12.11.3 Luye Pharma Group Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
12.11.4 Luye Pharma Group Transdermal Patch Products Offered
12.11.5 Luye Pharma Group Recent Development
12.12 Pfizer
12.12.1 Pfizer Corporation Information
12.12.2 Pfizer Business Overview
12.12.3 Pfizer Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
12.12.4 Pfizer Transdermal Patch Products Offered
12.12.5 Pfizer Recent Development
12.13 Chattem
12.13.1 Chattem Corporation Information
12.13.2 Chattem Business Overview
12.13.3 Chattem Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
12.13.4 Chattem Transdermal Patch Products Offered
12.13.5 Chattem Recent Development
12.14 Dr Reddy鈥檚 Laboratories
12.14.1 Dr Reddy鈥檚 Laboratories Corporation Information
12.14.2 Dr Reddy鈥檚 Laboratories Business Overview
12.14.3 Dr Reddy鈥檚 Laboratories Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
12.14.4 Dr Reddy鈥檚 Laboratories Transdermal Patch Products Offered
12.14.5 Dr Reddy鈥檚 Laboratories Recent Development
12.15 Bayer
12.15.1 Bayer Corporation Information
12.15.2 Bayer Business Overview
12.15.3 Bayer Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
12.15.4 Bayer Transdermal Patch Products Offered
12.15.5 Bayer Recent Development
12.16 Mundipharma
12.16.1 Mundipharma Corporation Information
12.16.2 Mundipharma Business Overview
12.16.3 Mundipharma Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
12.16.4 Mundipharma Transdermal Patch Products Offered
12.16.5 Mundipharma Recent Development
12.17 Endo International
12.17.1 Endo International Corporation Information
12.17.2 Endo International Business Overview
12.17.3 Endo International Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
12.17.4 Endo International Transdermal Patch Products Offered
12.17.5 Endo International Recent Development
12.18 Beijing Tide Pharmaceutical
12.18.1 Beijing Tide Pharmaceutical Corporation Information
12.18.2 Beijing Tide Pharmaceutical Business Overview
12.18.3 Beijing Tide Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
12.18.4 Beijing Tide Pharmaceutical Transdermal Patch Products Offered
12.18.5 Beijing Tide Pharmaceutical Recent Development
13 Transdermal Patch Manufacturing Cost Analysis
13.1 Transdermal Patch Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Transdermal Patch
13.4 Transdermal Patch Industrial Chain Analysis
14 麻豆原创ing Channel, Distributors and Customers
14.1 麻豆原创ing Channel
14.2 Transdermal Patch Distributors List
14.3 Transdermal Patch Customers
15 麻豆原创 Dynamics
15.1 Transdermal Patch Industry Trends
15.2 Transdermal Patch 麻豆原创 Drivers
15.3 Transdermal Patch 麻豆原创 Challenges
15.4 Transdermal Patch 麻豆原创 Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

Companies Mentioned:

Hisamitsu Pharmaceutical
Johnson & Johnson
Novartis
UCB Pharma
Mylan
Teva Pharmaceutical
Nitto Denko
骋谤眉苍别苍迟丑补濒
IBSA Group
GSK
Luye Pharma Group
Pfizer
Chattem
Dr Reddy鈥檚 Laboratories
Bayer
Mundipharma
Endo International
Beijing Tide Pharmaceutical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.